Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms

Simple item page

Simple item page

Full item details

creativework.keywords - en
Respiratory infections and tuberculosis
dc.contributor.author
Son, Kiho
Jamil, Rameen
Chowdhury, Abhiroop
Mukherjee, Manan
Venegas, Carmen
Miyasaki, Kate
Zhang, Kayla
Patel, Zil
Salter, Brittany
Yuen, Agnes Che Yan
Lau, Kevin Soon-Keen
Cowbrough, Braeden
Radford, Katherine
Huang, Chynna
Kjarsgaard, Melanie
Dvorkin-Gheva, Anna
Smith, James
Li, Quan-Zhen
Waserman, Susan
Ryerson, Christopher J.
Nair, Parameswaran
Ho, Terence
Balakrishnan, Narayanaswamy
Nazy, Ishac
Bowdish, Dawn M. E.
Svenningsen, Sarah
Carlsten, Chris
Mukherjee, Manali
dc.date.accessioned
2024-01-10T21:07:02Z
dc.date.available
2024-01-10T21:07:02Z
dc.date.issued
2023
dc.description.abstract - en
BACKGROUND: Autoimmunity has been reported in patients with severe coronavirus disease 2019 (COVID-19). We investigated whether anti-nuclear/extractable-nuclear antibodies (ANAs/ENAs) were present up to a year after infection, and if they were associated with the development of clinically relevant post-acute sequalae of COVID-19 (PASC) symptoms. METHODS: A rapid-assessment line immunoassay was used to measure circulating levels of ANAs/ENAs in 106 convalescent COVID-19 patients with varying acute phase severities at 3, 6 and 12 months post-recovery. Patient-reported fatigue, cough and dyspnoea were recorded at each time point. Multivariable logistic regression model and receiver operating curves were used to test the association of autoantibodies with patient-reported outcomes and pro-inflammatory cytokines. RESULTS: Compared to age- and sex-matched healthy controls (n=22) and those who had other respiratory infections (n=34), patients with COVID-19 had higher detectable ANAs at 3 months post-recovery (p<0.001). The mean number of ANA autoreactivities per individual decreased between 3 and 12 months (from 3.99 to 1.55) with persistent positive titres associated with fatigue, dyspnoea and cough severity. Antibodies to U1-snRNP and anti-SS-B/La were both positively associated with persistent symptoms of fatigue (p<0.028, area under the curve (AUC) 0.86) and dyspnoea (p<0.003, AUC=0.81). Pro-inflammatory cytokines such as tumour necrosis factor (TNF)-α and C-reactive protein predicted the elevated ANAs at 12 months. TNF-α, D-dimer and interleukin-1β had the strongest association with symptoms at 12 months. Regression analysis showed that TNF-α predicted fatigue (β=4.65, p=0.004) and general symptomaticity (β=2.40, p=0.03) at 12 months. INTERPRETATION: Persistently positive ANAs at 12 months post-COVID are associated with persisting symptoms and inflammation (TNF-α) in a subset of COVID-19 survivors. This finding indicates the need for further investigation into the role of autoimmunity in PASC.
dc.identifier.doi
https://doi.org/10.1183/13993003.00970-2022
dc.identifier.issn
0903-1936
dc.identifier.pubmedID
36137590
dc.identifier.uri
https://open-science.canada.ca/handle/123456789/1675
dc.language.iso
en
dc.publisher
European Respiratory Society
dc.rights - en
Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
dc.rights - fr
Creative Commons Attribution-Pas d’Utilisation Commerciale 4.0 International (CC BY-NC 4.0)
dc.rights.openaccesslevel - en
Gold
dc.rights.openaccesslevel - fr
Or
dc.rights.uri - en
https://creativecommons.org/licenses/by-nc/4.0/
dc.rights.uri - fr
https://creativecommons.org/licenses/by-nc/4.0/deed.fr
dc.subject - en
Health
dc.subject - fr
Santé
dc.subject.en - en
Health
dc.subject.fr - fr
Santé
dc.title - en
Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms
dc.type - en
Article
dc.type - fr
Article
local.acceptedmanuscript.articlenum
2200970
local.article.journalissue
1
local.article.journaltitle
European Respiratory Society
local.article.journalvolume
61
local.pagination
1-14
local.peerreview - en
Yes
local.peerreview - fr
Oui
Download(s)

Original bundle

Now showing 1 - 1 of 1

Thumbnail image

Name: son-circulating-anti-nuclear-autoantibodies.pdf

Size: 1.31 MB

Format: PDF

Download file

Page details

Date modified: